Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2014 1
2017 1
2018 1
2019 1
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Incidence and risk factors for norovirus-related diarrhea in Japanese geriatric intermediate care facilities: A prospective cohort study.
Suita A, Ohfuji S, Fukushima W, Ito K, Kase T, Kondo K, Ishibashi M, Kumashiro H, Kawai S, Deguchi A, Nakata H, Iba K, Kita T, Kinugawa K, Hamada K, Fujimoto M, Furukawa Y, Sowa E, Nakazawa H, Hirota Y. Suita A, et al. Among authors: ishibashi m. Geriatr Gerontol Int. 2023 Mar;23(3):179-187. doi: 10.1111/ggi.14539. Epub 2023 Jan 20. Geriatr Gerontol Int. 2023. PMID: 36669482
Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).
Kase T, Inoue M, Morikawa S, Kumashiro H, Hiroi S, Nakata K, Ito K, Ishibashi M, Tsuru T, Irie S, Maeda A, Ohfuji S, Fukushima W, Hirota Y. Kase T, et al. Among authors: ishibashi m. Vaccine. 2020 Sep 29;38(42):6524-6532. doi: 10.1016/j.vaccine.2020.08.025. Epub 2020 Aug 29. Vaccine. 2020. PMID: 32873406 Free article. Clinical Trial.
Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study.
Ito K, Mugitani A, Irie S, Ishibashi M, Takasaki Y, Shindo S, Yokoyama T, Yamashita Y, Shibao K, Koyanagi H, Fukushima W, Ohfuji S, Maeda A, Kase T, Hirota Y. Ito K, et al. Among authors: ishibashi m. Medicine (Baltimore). 2018 Jul;97(29):e11551. doi: 10.1097/MD.0000000000011551. Medicine (Baltimore). 2018. PMID: 30024549 Free PMC article. Clinical Trial.
Immunogenicity of the trivalent inactivated influenza vaccine in young children less than 4 years of age, with a focus on age and baseline antibodies.
Mugitani A, Ito K, Irie S, Eto T, Ishibashi M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Fukuoka Pediatricians Group for Vaccine Efficacy. Mugitani A, et al. Among authors: ishibashi m. Clin Vaccine Immunol. 2014 Sep;21(9):1253-60. doi: 10.1128/CVI.00200-14. Epub 2014 Jul 2. Clin Vaccine Immunol. 2014. PMID: 24990904 Free PMC article.